Skip to main content

Advertisement

SpringerLink
Log in

Legionella pneumophila pneumonia during telaprevir-based triple therapy for HCV chronic hepatitis

  • Correspondence
  • Published:
Infection Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Marks KM, Jacobson IM. The first wave: HCV NS3 protease inhibitors telaprevir and boceprevir. Antivir Ther. 2012;17:1119–31.

    Article  CAS  PubMed  Google Scholar 

  2. Hézode C, Fontaine H, Dorival C, et al. Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the french early access programme (anrs co20-cupic)—nct01514890. J Hepatol. 2013;59:434–41.

    Google Scholar 

  3. Maasoumy B, Port K, Markova AA, et al. Eligibility and safety of triple therapy for hepatitis C: lessons learned from the first experience in a real world setting. PLoS ONE. 2013;8:e552854.

    Article  Google Scholar 

  4. Mancini G, Erario L, Gianfreda R, et al. Tuberculosis and Legionella pneumophila pneumonia in a patient receiving anti-tumour necrosis factor-alpha (anti-TNF-alpha) treatment. Clin Microbiol Infect. 2007;13:1036–7.

    Article  CAS  PubMed  Google Scholar 

  5. Hametner S, Monticelli F, Kern JM, et al. Tuberculous sepsis during antiviral HCV triple therapy. J Hepatol. 2013;59:637–8.

    Google Scholar 

Download references

Conflict of interest

None to declare related to this study.

Author information

Authors and Affiliations

  1. Department of Public Health and Infectious Diseases, Fondazione Eleonora Lorillard Spencer Cenci, Sapienza University, Latina, Italy

    T. Tieghi, R. Marocco, V. Belvisi, C. Del Borgo, S. Savinelli, M. Lichtner & C. M. Mastroianni

  2. Infectious Disease Unit, SM Goretti Hospital, Sapienza University, Via Canova 4, 04100, Latina, Italy

    C. M. Mastroianni

Authors
  1. T. Tieghi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Marocco
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. V. Belvisi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Del Borgo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Savinelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Lichtner
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. C. M. Mastroianni
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. M. Mastroianni.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tieghi, T., Marocco, R., Belvisi, V. et al. Legionella pneumophila pneumonia during telaprevir-based triple therapy for HCV chronic hepatitis. Infection 42, 225–226 (2014). https://doi.org/10.1007/s15010-013-0543-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-013-0543-7

Keywords

Search

Navigation